share_log

CEN Biotech Inc. Announces Word Presto Partner Program

CEN Biotech Inc. Announces Word Presto Partner Program

CEN生物科技公司宣布Word Presto合作伙伴计划
Accesswire ·  2022/11/08 08:35

WINDSOR, ON / ACCESSWIRE / November 8, 2022 / CEN Biotech Inc. ("CEN" or the "Company") (OTCQB:CENBF), a global holding company focused on the development of leading-edge digital media technologies, LED lighting technology and hemp-based products, is pleased to announce the formal launch of its Word Presto Partner Program for resellers and affiliates.

CEN Biotech Inc.(“CEN”或“公司”)(OTCQB:CENBF)是一家全球控股公司,专注于数字媒体技术、LED照明技术和基于大麻的产品的开发,并荣幸地宣布正式推出其Word Presto合作伙伴计划,为代理商和联盟成员提供支持服务。

Word Presto is a product and a service that provides people with a customized web design experience coupled with affordable ongoing support and maintenance. To accompany our enterprise product and services, Word Presto has launched its Global Partner Program. This reseller program is designed for approved resellers and agencies to earn financial incentives for referring and selling the suite of Word Presto services.

Word Presto是一个提供个性化网页设计体验及合理的持续支持和维护服务的产品和服务。为了配合我们的企业型产品和服务,Word Presto推出了其全球合作伙伴计划。这个代理商计划是专为批准的代理商和机构设计的,以便为转介和销售Word Presto服务套件获得财务奖励。

Larry Lehoux, CEN's President and Chief Technology Officer, commented, "Our Word Presto Partner Program was aggressively designed to heavily compensate our business partners for their efforts in helping clients choose Word Presto for their website needs. All of the online sales are automatically tracked with an industry leading cookie that lasts for 60 days, as well as ongoing financial compensation for each sale that lasts for a year from the date of this initial purchase. We expect to have uptake in our offering from some targeted strategic partnerships in late 2022 and all throughout 2023."

CEN的总裁兼首席技术官Larry Lehoux评论道:“我们的Word Presto合作伙伴计划是积极设计的,旨在大力补偿我们的业务合作伙伴,在帮助客户选择Word Presto进行网站需求方面。所有在线销售均使用60天的业内领先Cookie自动跟踪,以及从初始购买日期起持续一年的每次销售的财务补偿。我们预计在2022年年底和2023年全年会有一些有针对性的战略伙伴关系的接纳。

You can learn more about the Word Presto partner offering by visiting the partner page located at

通过访问合作伙伴页面来了解有关Word Presto合作伙伴提供的更多信息:

About CEN Biotech Inc.

关于CEN Biotech Inc.:

CEN Biotech, Inc. is a global holding company focused on the development of digital media and LED lighting technology and hemp-based products. For further information on the Company, please visit our website at . Information about the Company can also be found on the Securities and Exchange Commission's (the "SEC") EDGAR site under the Issuer Profile of "CEN Biotech Inc."

CEN Biotech, Inc.是一家全球控股公司,专注于数字媒体、LED照明技术和大麻基础化学品的开发。有关公司的详细信息,请访问公司网站。有关该公司的信息也可以在美国证券交易委员会(“SEC”)的EDGAR网站上,在“CEN Biotech Inc.”的发行人概要下找到。

Forward Looking Statements

前瞻性声明

This press release contains "forward-looking" statements. In particular, the words "believe," "may," "could," "should," "expect," "anticipate," "estimate," "project," "propose," "plan," "intend," and similar conditional words and expressions are intended to identify forward-looking statements. Any statements made in this press release about an action, event or development, are forward-looking. These forward-looking statements are only predictions and are subject to certain risks, uncertainties, and assumptions, many of which may be beyond the control of CEN, that could cause actual results to differ from those in the forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. Although CEN believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Potential risks include such factors as the inability to enter into agreements with parties with whom we are in discussions, factors that cannot be predicted with certainty, as well as additional risks and uncertainties that are identified and described in CEN's reports filed with the SEC. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. Actual results may differ materially from the forward-looking statements in this press release. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. CEN does not undertake, and it specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement except as required in accordance with applicable laws.

本新闻稿包含“前瞻性”的声明。具体而言,“相信”、“可能”、“可能”、“应该”、“期望”、“预计”,“估计”、“项目”、“提案”、“计划”、“打算”和类似的条件词语和表达式旨在识别前瞻性声明。本新闻稿中所做的任何关于行动、事件或发展的声明均为前瞻性声明。这些前瞻性声明仅是预测,并受到某些可能超出CEN控制范围的风险、不确定性和假设的影响,这些因素可能导致实际结果与前瞻性声明中的结果不同。因此,您不应过度依赖这些前瞻性声明。虽然CEN认为前瞻性声明中反映的期望是合理的,但它不能保证其前瞻性声明将被证明是正确的。潜在风险包括与我们正在进行讨论的各方无法达成协议的因素、无法预测的因素,以及在CEN提交给SEC的报告中确定和描述的其他风险和不确定性。投资者应当意识到,任何前瞻性声明都不能保证未来的业绩,实际结果或发展可能与所述的前瞻性声明所预测的情况大相径庭。本新闻稿中所做的声明仅于本新闻稿发布日期有效,不应作为任何后续日期有效的参考。CEN不承担任何更新任何前瞻性声明以反映发生、发展、事件或情况的义务,除非依据适用法律规定。

Press Contact

新闻媒体联系人:

Brian S. Payne
Chief Executive Officer
CEN Biotech Inc.
Phone: (519) 981-0970
Email: brian@cenbiotechinc.com
Email: brian@nextrics.com

Brian S. Payne
首席执行官
CEN Biotech Inc.
电话:(519)981-0970
电子邮件:brian@cenbiotechinc.com
电子邮件:brian@nextrics.com

SOURCE: Cen Biotech, Inc.

消息来源:Cen Biotech, Inc.


View source version on accesswire.com:
在accesswire.com查看原始版本:

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发